Ilaria Ferrari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ilaria Ferrari has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Grazia Pietrini
Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milan, Italy
7 shared publications Arianna Crespi
Institute of Neuroscience, Consiglio Nazionale delle Ricerche, Milan, Italy
5 shared publications- Diego Fornasari
Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, 20122 Milan, Italy
3 shared publications - Valeria Padovano
Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
3 shared publications - Antonello Villa
Consorzio MIA (Microscopy and Image Analysis), University of Milano-Bicocca, Milan, Italy
2 shared publications - Giorgio Scita
IFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy
2 shared publications
Latest Publications
- 2 November 2021
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 17 (3) , 921-924
Patient adherence and comprehension of take-home anticoagulant regimens prescribed at the emergency department: preliminary findings from a randomized controlled trial and implications for patient safety
- 2 November 2021
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 17 (3) , 921-924
Patient adherence and comprehension of take-home anticoagulant regimens prescribed at the emergency department: preliminary findings from a randomized controlled trial and implications for patient safety
- 1 July 2021
- Published by Ernst Reinhardt, GmbH & Co. KG in motorik
- Vol. 44 (3) , 122-131
Fachbeitrag: Bewegungsaktivitäten im Alltag und motorische Basiskompetenzen im Kindergartenalter
Das Sammeln vielseitiger Bewegungserfahrungen und der Aufbau der motorischen Handlungsfähigkeit gelten als wichtige Entwicklungsaspekte der frühen Kindheit. Dabei repräsentieren das Spielen im Freien, Sporttreiben in der Freizeit sowie ein aktiv bewältigter Schulweg grundlegende Erfahrungsräume der Lebenswelt von Kindern. Im Rahmen der vorliegenden Querschnittstudie mit 478 Kindergartenkindern aus zwei Kantonen der Schweiz wurde überprüft, inwiefern sich aufgrund der Häufigkeit dieser Bewegungsformen relevante Unterschiede bei den motorischen Basiskompetenzen (MOBAK) nachweisen lassen. Die Analyse zeigt, dass Kinder, die ihren Schulweg aktiv bewältigten, in ihrer Freizeit häufig im Freien spielten oder sportlich aktiv waren, insgesamt über ein besseres motorisches Niveau verfügen.
- 1 July 2021
- Published by Ernst Reinhardt, GmbH & Co. KG in motorik
- Vol. 44 (3) , 122-131
Fachbeitrag: Bewegungsaktivitäten im Alltag und motorische Basiskompetenzen im Kindergartenalter
Das Sammeln vielseitiger Bewegungserfahrungen und der Aufbau der motorischen Handlungsfähigkeit gelten als wichtige Entwicklungsaspekte der frühen Kindheit. Dabei repräsentieren das Spielen im Freien, Sporttreiben in der Freizeit sowie ein aktiv bewältigter Schulweg grundlegende Erfahrungsräume der Lebenswelt von Kindern. Im Rahmen der vorliegenden Querschnittstudie mit 478 Kindergartenkindern aus zwei Kantonen der Schweiz wurde überprüft, inwiefern sich aufgrund der Häufigkeit dieser Bewegungsformen relevante Unterschiede bei den motorischen Basiskompetenzen (MOBAK) nachweisen lassen. Die Analyse zeigt, dass Kinder, die ihren Schulweg aktiv bewältigten, in ihrer Freizeit häufig im Freien spielten oder sportlich aktiv waren, insgesamt über ein besseres motorisches Niveau verfügen.
- Open Access
- 4 May 2018
- Published by Taylor & Francis in Communicative & Integrative Biology
- Vol. 11 (3) , 1-7
SOD1 stimulates lamellipodial protrusions in Neuro 2A cell lines
We here investigated the effects of overexpressed superoxide dismutase (SOD)1 and amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants G93A and G147S in Neuro 2A (N2A) cell lines, and found a three-fold increase in lamellipodia either in cells cultured under differentiated or undifferentiated growth conditions. In undifferentiated N2A cells, SOD1 constructs promoted lamellipodial protrusions to similar extent as the overexpression of Rac1, and SOD1-mediated lamellipodia were prevented by coexpression of the N17 dominant-negative form of Rac1, or shRNA for a downstream effector of Rac1, the insulin receptor tyrosine kinase substrate p53 (IRSp53) or its binding partner LIN7. Moreover, no additive effect was measured by coexpression of the SOD1 constructs with Rac1, IRSp53 or LIN7. Collectively these data support a role for SOD1 in the regulation of Rac1-mediated lamellipodia pathway, a property fully retained by the two SOD1 mutants.
- 4 May 2018
- Published by Taylor & Francis in Communicative & Integrative Biology
- Vol. 11 (3) , 1-7
Open AccessSOD1 stimulates lamellipodial protrusions in Neuro 2A cell lines
We here investigated the effects of overexpressed superoxide dismutase (SOD)1 and amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants G93A and G147S in Neuro 2A (N2A) cell lines, and found a three-fold increase in lamellipodia either in cells cultured under differentiated or undifferentiated growth conditions. In undifferentiated N2A cells, SOD1 constructs promoted lamellipodial protrusions to similar extent as the overexpression of Rac1, and SOD1-mediated lamellipodia were prevented by coexpression of the N17 dominant-negative form of Rac1, or shRNA for a downstream effector of Rac1, the insulin receptor tyrosine kinase substrate p53 (IRSp53) or its binding partner LIN7. Moreover, no additive effect was measured by coexpression of the SOD1 constructs with Rac1, IRSp53 or LIN7. Collectively these data support a role for SOD1 in the regulation of Rac1-mediated lamellipodia pathway, a property fully retained by the two SOD1 mutants.
- Top Cited Papers
- 12 December 2016
- Published by Wiley in Clinical Genetics
- Vol. 91 (2) , 183-198
Genetics of primary ovarian insufficiency
Primary ovarian insufficiency (POI) is characterized by a loss of ovarian function before the age of 40 and account for one major cause of female infertility. POI relevance is continuously growing because of the increasing number of women desiring conception beyond 30 years of age, when POI prevalence is >1%. POI is highly heterogeneous and can present with ovarian dysgenesis and primary amenorrhea, or with secondary amenorrhea, and it can be associated with other congenital or acquired abnormalities. In most cases POI remains classified as idiopathic. However, the age of menopause is an inheritable trait and POI has a strong genetic component. This is confirmed by the existence of several candidate genes, experimental and natural models. The variable expressivity of POI defect may indicate that, this disease may frequently be considered as a multifactorial or oligogenic defect. The most common genetic contributors to POI are the X chromosome‐linked defects. Here, we review the principal X‐linked and autosomal genes involved in syndromic and non‐syndromic forms of POI with the expectation that this list will soon be upgraded, thus allowing the possibility to predict the risk of an early age at menopause in families with POI.
- 12 December 2016
- Published by Wiley in Clinical Genetics
- Vol. 91 (2) , 183-198
Top Cited PapersGenetics of primary ovarian insufficiency
Primary ovarian insufficiency (POI) is characterized by a loss of ovarian function before the age of 40 and account for one major cause of female infertility. POI relevance is continuously growing because of the increasing number of women desiring conception beyond 30 years of age, when POI prevalence is >1%. POI is highly heterogeneous and can present with ovarian dysgenesis and primary amenorrhea, or with secondary amenorrhea, and it can be associated with other congenital or acquired abnormalities. In most cases POI remains classified as idiopathic. However, the age of menopause is an inheritable trait and POI has a strong genetic component. This is confirmed by the existence of several candidate genes, experimental and natural models. The variable expressivity of POI defect may indicate that, this disease may frequently be considered as a multifactorial or oligogenic defect. The most common genetic contributors to POI are the X chromosome‐linked defects. Here, we review the principal X‐linked and autosomal genes involved in syndromic and non‐syndromic forms of POI with the expectation that this list will soon be upgraded, thus allowing the possibility to predict the risk of an early age at menopause in families with POI.
- Open Access
- 23 October 2016
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 25 (23) , 5223-5233
Impaired protein stability and nuclear localization ofNOBOXvariants associated with premature ovarian insufficiency
Premature ovarian insufficiency (POI) is a clinical syndrome defined by a loss of ovarian activity before the age of 40. Its pathogenesis is still largely unknown, but increasing evidences support a genetic basis in most cases. Among these, heterozygous mutations in NOBOX, a homeobox gene encoding a transcription factor expressed specifically by oocyte and granulosa cells within the ovary, have been reported in ∼6% of women with sporadic POI. The pivotal role of NOBOX in early folliculogenesis is supported by findings in knock-out mice. Here, we report the genetic screening of 107 European women with idiopathic POI, recruited in various settings, and the molecular and functional characterization of the identified variants to evaluate their involvement in POI onset. Specifically, we report the identification of two novel and two recurrent heterozygous NOBOX variants in 7 out of 107 patients, with a prevalence of 6.5% (upper 95% confidence limit of 11.17%). Furthermore, immunolocalization, Western Blot and transcriptional assays conducted in either HEK293T or CHO cells revealed that all the studied variants (p.R44L, p.G91W, p.G111R, p.G152R, p.K273*, p.R449* and p.D452N) display variable degrees of functional impairment, including defects in transcriptional activity, autophagosomal degradation, nuclear localization or protein instability. Several variants conserve the ability to interact with FOXL2 in intracellular aggregates. Their inability to sustain gene expression, together with their likely aberrant effects on protein stability and degradation, make the identified NOBOX mutations a plausible cause of POI onset.
- 23 October 2016
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 25 (23) , 5223-5233
Open AccessImpaired protein stability and nuclear localization ofNOBOXvariants associated with premature ovarian insufficiency
Premature ovarian insufficiency (POI) is a clinical syndrome defined by a loss of ovarian activity before the age of 40. Its pathogenesis is still largely unknown, but increasing evidences support a genetic basis in most cases. Among these, heterozygous mutations in NOBOX, a homeobox gene encoding a transcription factor expressed specifically by oocyte and granulosa cells within the ovary, have been reported in ∼6% of women with sporadic POI. The pivotal role of NOBOX in early folliculogenesis is supported by findings in knock-out mice. Here, we report the genetic screening of 107 European women with idiopathic POI, recruited in various settings, and the molecular and functional characterization of the identified variants to evaluate their involvement in POI onset. Specifically, we report the identification of two novel and two recurrent heterozygous NOBOX variants in 7 out of 107 patients, with a prevalence of 6.5% (upper 95% confidence limit of 11.17%). Furthermore, immunolocalization, Western Blot and transcriptional assays conducted in either HEK293T or CHO cells revealed that all the studied variants (p.R44L, p.G91W, p.G111R, p.G152R, p.K273*, p.R449* and p.D452N) display variable degrees of functional impairment, including defects in transcriptional activity, autophagosomal degradation, nuclear localization or protein instability. Several variants conserve the ability to interact with FOXL2 in intracellular aggregates. Their inability to sustain gene expression, together with their likely aberrant effects on protein stability and degradation, make the identified NOBOX mutations a plausible cause of POI onset.
- Open Access
- 12 August 2016
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 17 (8) , 1332
The Role of Cyclo(His-Pro) in Neurodegeneration
Neurodegenerative diseases may have distinct genetic etiologies and pathological manifestations, yet share common cellular mechanisms underpinning neuronal damage and dysfunction. These cellular mechanisms include excitotoxicity, calcium dysregulation, oxidative damage, ER stress and neuroinflammation. Recent data have identified a dual role in these events for glial cells, such as microglia and astrocytes, which are able both to induce and to protect against damage induced by diverse stresses. Cyclo(His-Pro), a cyclic dipeptide derived from the hydrolytic removal of the amino-terminal pyroglutamic acid residue of the hypothalamic thyrotropin-releasing hormone, may be important in regulating the nature of the glial cell contribution. Cyclo(His-Pro) is ubiquitous in the central nervous system and is a key substrate of organic cation transporters, which are strongly linked to neuroprotection. The cyclic dipeptide can also cross the brain-blood-barrier and, once in the brain, can affect diverse inflammatory and stress responses by modifying the Nrf2-NF-κB signaling axis. For these reasons, cyclo(His-Pro) has striking potential for therapeutic application by both parenteral and oral administration routes and may represent an important new tool in counteracting neuroinflammation-based degenerative pathologies. In this review, we discuss the chemistry and biology of cyclo(His-Pro), how it may interact with the biological mechanisms driving neurodegenerative disease, such as amyotrophic lateral sclerosis, and thereby act to preserve or restore neuronal function.
- 12 August 2016
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 17 (8) , 1332
Open AccessThe Role of Cyclo(His-Pro) in Neurodegeneration
Neurodegenerative diseases may have distinct genetic etiologies and pathological manifestations, yet share common cellular mechanisms underpinning neuronal damage and dysfunction. These cellular mechanisms include excitotoxicity, calcium dysregulation, oxidative damage, ER stress and neuroinflammation. Recent data have identified a dual role in these events for glial cells, such as microglia and astrocytes, which are able both to induce and to protect against damage induced by diverse stresses. Cyclo(His-Pro), a cyclic dipeptide derived from the hydrolytic removal of the amino-terminal pyroglutamic acid residue of the hypothalamic thyrotropin-releasing hormone, may be important in regulating the nature of the glial cell contribution. Cyclo(His-Pro) is ubiquitous in the central nervous system and is a key substrate of organic cation transporters, which are strongly linked to neuroprotection. The cyclic dipeptide can also cross the brain-blood-barrier and, once in the brain, can affect diverse inflammatory and stress responses by modifying the Nrf2-NF-κB signaling axis. For these reasons, cyclo(His-Pro) has striking potential for therapeutic application by both parenteral and oral administration routes and may represent an important new tool in counteracting neuroinflammation-based degenerative pathologies. In this review, we discuss the chemistry and biology of cyclo(His-Pro), how it may interact with the biological mechanisms driving neurodegenerative disease, such as amyotrophic lateral sclerosis, and thereby act to preserve or restore neuronal function.
- 1 August 2016
- Published by Elsevier in European Journal of Cell Biology
- Vol. 95 (8) , 285-293
Novel localisation and possible function of LIN7 and IRSp53 in mitochondria of HeLa cells
- 1 August 2016
- Published by Elsevier in European Journal of Cell Biology
- Vol. 95 (8) , 285-293
Novel localisation and possible function of LIN7 and IRSp53 in mitochondria of HeLa cells
- 1 January 2015
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 135 (1) , 192-201
POF1B Localizes to Desmosomes and Regulates Cell Adhesion in Human Intestinal and Keratinocyte Cell Lines
- 1 January 2015
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 135 (1) , 192-201
POF1B Localizes to Desmosomes and Regulates Cell Adhesion in Human Intestinal and Keratinocyte Cell Lines
- Open Access
- 5 November 2012
- Published by Taylor & Francis in Communicative & Integrative Biology
- Vol. 5 (6) , 631-633
LIN7-IRSp53: A novel pathway for filopodia and neurite formation?
Filopodia are dynamic, actin-rich finger-like structures that protrude from the cell membrane and play important roles in cell migration and neurite initiation and outgrowth. The insulin receptor s...
- 5 November 2012
- Published by Taylor & Francis in Communicative & Integrative Biology
- Vol. 5 (6) , 631-633
Open AccessLIN7-IRSp53: A novel pathway for filopodia and neurite formation?
Filopodia are dynamic, actin-rich finger-like structures that protrude from the cell membrane and play important roles in cell migration and neurite initiation and outgrowth. The insulin receptor s...
- Open Access
- 1 January 2012
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 125 (19) , 4543-4554
LIN7 regulates the filopodia and neurite promoting activity of IRSp53
The insulin receptor substrate protein of 53 kDa (IRSp53) is critically involved in the formation of filopodia and neurites through mechanisms that have only in part been clarified. Here, we investigated the role of the small scaffold protein LIN7, an interactor of IRSp53. We found that formation of actin-filled protrusions in neuronal NSC34 cells and neurites in neuroblastoma N2A depends on motifs mediating the LIN7:IRSp53 association, as both the coexpression of LIN7 with IRSp53 or the expression of the L27-IRSp53 chimera (a fusion protein between IRSp53 and the LIN7L27 domain for plasma membrane protein complexes association) prevented actin-deficient protrusions induced by overexpressed IRSp53, and enhanced the formation of actin-filled protrusions. The regulatory role of LIN7 in IRSp53-mediated extension of filopodia was demonstrated by live-cell imaging experiments in neuronal N2A cells. Moreover, LIN7 silencing prevented the extension of filopodia and neurites, induced by ectopic expression of IRSp53 or serum starvation, respectively in undifferentiated and differentiated N2A cells. The expression of full length IRSp53 or the LIN7ΔPDZ mutant lacking the domain for association with IRSp53 was unable to restore neuritogenesis in LIN7 silenced cells. Conversely, defective neuritogenesis could be rescued by the expression of RNAi-resistant full length LIN7 or chimeric L27-IRSp53. Finally, LIN7 silencing prevented the recruitment of IRSp53 in Triton X-100 insoluble complexes, otherwise occurring in differentiated cells. Collectively these data indicate that LIN7 is a novel regulator of IRSp53, and that their association is required to promote the formation of actin-dependent filopodia and neurites.
- 1 January 2012
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 125 (19) , 4543-4554
Open AccessLIN7 regulates the filopodia and neurite promoting activity of IRSp53
The insulin receptor substrate protein of 53 kDa (IRSp53) is critically involved in the formation of filopodia and neurites through mechanisms that have only in part been clarified. Here, we investigated the role of the small scaffold protein LIN7, an interactor of IRSp53. We found that formation of actin-filled protrusions in neuronal NSC34 cells and neurites in neuroblastoma N2A depends on motifs mediating the LIN7:IRSp53 association, as both the coexpression of LIN7 with IRSp53 or the expression of the L27-IRSp53 chimera (a fusion protein between IRSp53 and the LIN7L27 domain for plasma membrane protein complexes association) prevented actin-deficient protrusions induced by overexpressed IRSp53, and enhanced the formation of actin-filled protrusions. The regulatory role of LIN7 in IRSp53-mediated extension of filopodia was demonstrated by live-cell imaging experiments in neuronal N2A cells. Moreover, LIN7 silencing prevented the extension of filopodia and neurites, induced by ectopic expression of IRSp53 or serum starvation, respectively in undifferentiated and differentiated N2A cells. The expression of full length IRSp53 or the LIN7ΔPDZ mutant lacking the domain for association with IRSp53 was unable to restore neuritogenesis in LIN7 silenced cells. Conversely, defective neuritogenesis could be rescued by the expression of RNAi-resistant full length LIN7 or chimeric L27-IRSp53. Finally, LIN7 silencing prevented the recruitment of IRSp53 in Triton X-100 insoluble complexes, otherwise occurring in differentiated cells. Collectively these data indicate that LIN7 is a novel regulator of IRSp53, and that their association is required to promote the formation of actin-dependent filopodia and neurites.